Personalized Medicine, by Your DNA

Pharmacogenetic testing takes the guesswork out of prescriptions, so patients get the right treatment, the first time.

Unlock Better Outcomes with Pharmacogenetic Testing

Everyone’s DNA is unique, and so is the way we respond to medications. Pharmacogenetic (PGx) testing reveals how your genes influence drug metabolism, safety, and effectiveness. Instead of trial-and-error, providers can prescribe with confidence, in a seamlessly with Nymara AI, delivering safer, more effective care from the start.

A serene image of a patient smiling and feeling relieved after receiving personalized treatment based on their genetic makeup, showcasing the positive impact of pharmacogenetics on patient well-being.
For Patients: Personalized Relief
A professional image of a doctor confidently reviewing a patient's pharmacogenetic report, highlighting the data-driven insights that empower providers to make informed decisions.
For Providers: Data-Driven Decisions
An image representing a healthcare system with reduced costs and improved efficiency, symbolizing the positive impact of pharmacogenetics on healthcare economics and patient outcomes.
For Healthcare Systems: Lower Costs

More Than a Test—A Complete Care Platforms

With Precision Genetics, pharmacogenetic insights don’t stop at a single test. Nymara enables ongoing patient monitoring, updating recommendations as medications and health conditions change. This combination of AI, genetics, and real-time data keeps patients safer, treatments more effective, and costs under control. This is why WaiveDx is leading the future of healthcare.
A digital illustration depicting a patient's health data being continuously monitored and updated in real-time, showcasing the dynamic nature of WaiveDx's platform.
Real-Time Data Updates
Our platform ensures that treatment plans are always based on the most current information, adapting to changes in medication and health conditions for optimal patient care.
An image of a doctor reviewing a patient's genetic report on a tablet, highlighting the ease of access and actionable insights provided by WaiveDx's AI-driven reporting engine.
AI-Driven Insights
Nymara analyzes complex interactions to deliver concise, actionable insights, empowering providers to make informed decisions and improve patient outcomes effectively.
A graphic representing the integration of genetic data, AI, and real-time monitoring to create a comprehensive care platform that prioritizes patient safety and cost-effectiveness.
Comprehensive Care Platform
WaiveDx integrates genetics, AI, and real-time data to provide a complete care platform that prioritizes patient safety, treatment effectiveness, and cost control.